Press Releases

Pathway to Stop Diabetes will provide funding for innovative diabetes researchers

- Collaboration represents the first time the ACC’s PINNACLE Registry Research Alliance will be used for clinical trial recruitment -

Developing approaches for involving patients in drug development

- Similar glucose lowering effect when once-daily Lyxumia is administered before breakfast or the main meal -

- EDITION II trial demonstrates similar blood sugar control with fewer night-time low blood sugar events for U300 compared with Lantus® -

- Sarilumab, Given Subcutaneously Every Other Week, Met All Three Co-Primary Endpoints -

- Nasal Spray Treats Adults and Children with Seasonal and Year-Round Nasal Allergies -

Event Builds on Tradition of Corporate Citizenship and Community

New online resource provides customized tools, resources developed by leading Grandparent Expert to help grandparents learn more about highly contagious, often serious disease

- Findings Consistent with Known Post-Prandial Effect of Lyxumia Supporting Combination with Basal Insulin -

Campaign harnesses positive peer influence and power of social media to help drive flu vaccination among #FLUgitives

-- Addition of Iconic Brand Bolsters U.S. Consumer Healthcare Business --

- Efficacy trial in more than 30,000 older adults meets primary endpoint for superior efficacy -

- Majority of Survey Respondents Reported They or Their Child Experienced a Severe Allergic Reaction While Traveling -

Cdiffense trial to evaluate vaccine against a leading cause of life-threatening, healthcare-associated infections worldwide

- Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children -

- Largest supplier of influenza vaccine in U.S., first to ship, will distribute more than 60 million doses of flu vaccines for fall immunization campaigns -

- EDITION I demonstrated similar blood sugar control with fewer night-time low blood sugar events compared to Lantus® -

-- Lixisenatide decreased HbA1c by reducing PPG when added to basal insulin with or without oral anti-diabetic agents --

- Headfirst! Expert Advice on Lice Offers Moms and Healthcare Providers Helpful Tools and Resources to Overcome Head Lice -

- "Get in the Game" urges parents to take action and vaccinate against meningococcal disease in advance of the upcoming sports season

New Fluzone® Quadrivalent (Influenza Virus Vaccine):

Campaign Continues to Educate Adults on How to Help Protect Themselves and How to Help Stop the Spread of Pertussis to Infants

- Connect & Coach™ Awarded $100,000 to Further Develop its Novel Solution to Help Improve Health Outcomes for People Living with Diabetes -

- Bettis Unveils New Playbook for Defending Against Severe Allergic Reactions and Urges Those Affected to Take Action -

The same trusted formula in an easy aim spray

-Donation to Diabetes Hands Foundation Doubled When Documentary Reaches 10,000 Views-

Growth platforms(2) sales increased 8.6%(3)

Donation to fund instrumentation and scholarships for university science and technology programs

Over-the-Counter Allergy Brand Now Offers Topical Relief for Itchy, Dry Skin Just in Time for Summer

Game On! Leslie and Sanofi's Chattem Encourage Families to Put Seasonal Allergies Behind Them and Stay Active This Spring

National Patient Spokesperson Melanie Bloom Commemorates Significant Achievements to Raise Awareness of DVT and Potentially Fatal Complication, Pulmonary Embolism

Pathway to Stop Diabetes to provide funding for innovative diabetes researchers

- Sanofi US to Donate Up to $100,000 to Patient Organizations -

- Bettis and Miller, Both at Risk for Anaphylaxis, Join Forces with Sanofi US to Introduce Auvi-Q (Epinephrine Injection, USP) and Serve Up Allergy-Friendly Tips for Big Game Parties -

--LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels--

-- Breakthrough device design talks patients and caregivers through the injection process --

- NBA All-Stars Andre Iguodala and Danny Granger and Seven-Time WNBA All-Star Tamika Catchings to Help Raise Awareness about Diabetes -

-- Product acquisition further strengthens Consumer Healthcare Division of Sanofi US --

- Company’s annual Adopt-a-Family drive delivers essential items to local families in need -

- Registries for All Diseases wins $300k to create crowdsourced cross-disease registry -

Pathway to Stop Diabetes to Provide Funding for Innovative Diabetes Researchers

- New Data Presented at American Society of Hematology Annual Meeting Show Activity Against Disease and Symptom Alleviation -

Response Includes Contribution to Three New Jersey Area Organizations

- Two-Dose Series Given at Regularly Scheduled Pediatric Visits Demonstrates Strong Immune Responses -

Growth Platforms(2) reached over 70% of sales

- QIV is the next evolution of influenza vaccine designed to help protect against influenza B, a significant cause of influenza illness and associated complications across all ages, and especially children -

– CDC analysis of 10 influenza seasons indicates use of a four-strain vaccine could have prevented 2.7 million influenza cases, 21 thousand influenza-related hospitalizations and almost 1,400 influenza-related deaths(1) –

Establishment of joint project teams will leverage strengths of academic and industry cross-organizational expertise in all stages of translational research

U.S. Senator Robert P. Casey, Jr. and Former First Lady Of Pennsylvania Ellen Casey Co-Chair Event

- Goal is to select novel clinical development candidates to help stop the global pandemic -

- Everyone 6 months of age and older recommended for yearly vaccination

Recent survey findings indicate majority of adults fear spreading the flu to family and friends, yet only a third of adults 18 through 64 years of age get a flu shot

- New Prescription Lotion Offers Effective Treatment Option -

-- Breakthrough device design talks patients and caregivers through the injection process --

Technology can provide increased accuracy, efficiency for medical practices

- Four local non-profits receive donations totaling more than $185,000 -

Novel Ideas Sought on How to Better Engage Patients in Their Health

Research collaboration to explore novel target shown in pre-clinical studies to play significant role in type 1 diabetes

- Early shipments of flu vaccine allow health care providers to begin immunization and clinic plans with confidence in vaccine supply -

- Research collaboration with affiliate of Harvard Medical School aims to develop novel therapeutic approaches -

Nearly three-quarters of parents ask caregivers to use approved car safety seats and wash/sanitize their hands, yet fewer than one-fifth ask them to get an adult pertussis vaccine

- No increased risk of cancer found with Lantus® in new European and U.S. observational studies -

- Lixisenatide with basal insulin helped type 2 diabetes patients with uncontrolled HbA1c achieve target blood glucose levels -

- First FDA Cleared Blood Glucose Meter that Connects Directly to iPhone® and iPod touch® -

- Pediatric Data Supplements Prior Phase II and Phase III Studies in Adults -

Birmingham Program to Improve Diabetes Management through Behavioral Economics

- Fox Foundation to sponsor a clinical trial to study Sanofi compound -

- Sanofi to commercialize LeGoo® a highly innovative FDA approved and CE marked gel that provides temporary blood vessel occlusion during surgery -

Fewer Than One in Three Survey Participants Discussed DVT/PE with Healthcare Professional

Dale and Frances Hughes Cancer Center to Receive $500,000 Donation

Challenge Now Accepting Submissions From Health Innovators and Entrepreneurs

Net Sales and Business EPS(1) up 9.2%(2) in Q4

-- Product to be commercialized by Sanofi Pasteur U.S. - an established leader in pediatric healthcare --

-- Product to be commercialized by Sanofi Pasteur U.S. - an established leader in pediatric healthcare --

- NBA Star Carlos Boozer, WNBA All-Star Tamika Catchings, NBA Legend Bob Lanier and New Jersey Nets Head Coach Avery Johnson to Serve as Campaign Ambassadors -

JOINTLY RELEASED BY SANOFI AND THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

- Ruling Provides for Restricted U.S. Launch Prior to April Trial Date -